The Avayle team is led by top executives with decades of experience in the pharmaceutical industry and in clinical trial management. Our in-depth understanding of strategic planning, global procurement, supply forecasting, and project management work to help our clients achieve success. We will strive tirelessly on your behalf to develop smart strategies that meet the challenges of your trial and ensure efficient delivery of the supplies you need, when you need them. We will be there for you every step of the way.

Avayle Leadership Team

Morse, Lorann

Lorann Morse, Co-Founder

A leading pharmaceutical executive with more than 25 years of experience on both vendor-side and pharma, Lorann has developed and implemented successful strategies across the Clinical Supply Management industry.

Prior to co-founding Avayle in 2018, she was Director, Clinical Supply Management at Nektar Therapeutics with responsibility for strategic oversight and team leadership. From 2012 to 2014, she served in senior roles at Clinigen CTS, first as Global Commercial Director and then Senior Vice President. Responsible for management of the CTS Global division, Lorann provided commercial and strategic leadership, global forecasting, marketing, and strategic client relations. Prior to Clinigen, Lorann was Director of Clinical Services at Myoderm where as a member of the executive team she was responsible for strategy and implementation of CentralSource as well as other key leadership areas. From 2004 to 2008, she was Senior Manager, Clinical Supplies, at Shire Development Inc., developing and managing the strategy in the delivery and maintenance of global clinical trials. Lorann also has served in positions at BlisTech and Procter and Gamble Pharmaceuticals.

Lorann holds a Bachelor’s degree in Leadership Studies from Villanova University. She received her certification as a Medical Laboratory Technician from the State University of New York.

Bishop, Tammy

Tammy Bishop, Co-Founder

As a business leader with more than 20 years of experience in the pharmaceutical industry, Tammy is responsible for streamlining the complex process of comparator procurement into an organized, centralized system that enables sponsor companies to save millions of dollars over the life of a clinical trial. As partner in a women-owned business, Tammy is a thought leader who pursues and promotes opportunities for diverse small companies in the life sciences sector.

Prior to co-founding Avayle in 2018, she worked in senior leadership roles at clinical trial supply firm CaligorRx. She served as Managing Director of the company from 2010 to 2016, overseeing significant revenue growth and geographic expansion, and later as Chief Executive Officer and Chief Commercial Officer following the acquisition of CaligorRx by private equity firm Diversis Capital, LLC. Her industry expertise includes senior-level business development positions at Pharmarama International and IDIS Pharmaceuticals. She also has served in senior investor relations and corporate communications positions at OXiGENE, Gemini Genomics and Indevus Pharmaceuticals.

Tammy’s corporate and non-profit governance experience includes board positions with CaligorRx and Diversity Alliance for Science, a national organization that fosters diversity in the life science industry. She also has served as a member of the Drug Information Association, Healthcare Distribution Management Association, Healthcare Women’s Business Association and Institute for Supply Chain Management. Tammy received a Master’s Degree in Business Administration from the Simmons College School of Management.